Kenilworth, New Jersey

May 12, 2020

Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing

Mar 19, 2020

Dragonfly Therapeutics Announces Multi-Target Expansion of its Collaboration with Merck to Use Dragonfly's Proprietary TriNKET(TM) Platform to Develop Novel Therapeutic Candidates in the fields of Oncology, Infectious Disease, and Immune Disorders

Oct 01, 2019

Global Immuno-Oncology Market Report 2019-2023 - Evolution of Biosimilars in Oncology / Accelerating Immuno-Oncology Research / Purchasing and Reimbursement Actions

Jul 08, 2019

Skyhawk Therapeutics Announces Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing

Feb 05, 2019

G-CON PODs® Selected for New Merck FLEx Center Project

Jan 14, 2019

Alopexx Vaccine Announces Licensing Agreement with Merck Animal Health

Jan 03, 2019

Inovio Announces Appointments to its Board of Directors

Sep 11, 2018

Advisory - Marvelon 28 birth control pills: Packages do not contain day-of-the-week stickers

Nov 28, 2017

ImmunoMet Appoints Briggs W. Morrison, M.D., and Paul Lammers, M.D., M.Sc., to Board of Directors

Oct 02, 2017

SELLAS Enters into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc., Kenilworth, N.J., USA

Aug 22, 2017

TARA Biosystems Appoints Pharmaceutical Industry Leader, Michael P. Graziano, Ph.D., as Chief Scientific Officer